SCHEMBL2890

SCHEMBL2890

Cc1ccc(S(=O)(=O)OCc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 3/20 0.53
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
LMNA P02545 2/20 0.52
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
BCHE P06276 1/20 0.51
ACHE P22303 1/20 0.51
CA12 O43570 1/20 0.51
ATM Q13315 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
AR P10275 1/20 0.51
MAPT P10636 2/20 0.49
MCHR1 Q99705 1/20 0.49
PIR O00625 1/20 0.47
VDR P11473 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CNR2 P34972 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL9257721 0.98 CA9 (0.51) CA9CA1CA2LMNACYP1A2
Ammonia Solution, Strong SCHEMBL9470841 0.98 CA9 (0.51) CA9CA1CA2LMNACYP1A2
N,N-Dimethylethanaminium SCHEMBL11574804 0.91 LMNA (0.46) CA9CA1CA2LMNACYP1A2
SCHEMBL6859827 0.91 CA2 (0.63) CA9CA1CA2CYP3A4BCHE
SCHEMBL8052920 0.91 CA2 (0.63) CA9CA1CA2CYP3A4BCHE
Glycine SCHEMBL6795033 0.89 LMNA (0.51) CA9CA1CA2LMNACYP1A2
SCHEMBL27966350 0.88 MAPT (0.48) CA9CA1CA2LMNACYP1A2
SCHEMBL4947525 0.88 CYP19A1 (0.53) CA9CA1CA2LMNACYP1A2
Alanine SCHEMBL21580304 0.87 LMNA (0.49) CA9CA1CA2LMNACYP1A2
D-Alanine SCHEMBL21580302 0.87 LMNA (0.49) CA9CA1CA2LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 919 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4656669-A1 FLUORINATED COPOLYMERS BASED ON AN OLIGO(2-OXAZOLINE) MACROMONOMER ARKEMA FRANCE (FR) 2025-12-03 EP claimed
CN-120025254-A Preparation method of epothilone hydrochloride intermediate 甘肃皓天医药科技有限责任公司 2025-05-23 CN claimed
CN-114213323-B New process for synthesizing procaterol hydrochloride 四川美域高生物医药科技有限公司 2023-06-02 CN claimed
CN-114105872-B Intermediate for preparing procaterol hydrochloride and preparation method thereof 四川美域高生物医药科技有限公司 2023-05-23 CN claimed
CN-114195712-B Intermediate capable of being used for preparing procaterol hydrochloride and preparation method thereof 四川美域高生物医药科技有限公司 2023-05-16 CN claimed
CN-114213323-A Novel process for synthesizing procaterol hydrochloride 四川美域高生物医药科技有限公司 2022-03-22 CN claimed
CN-114195712-A Intermediate capable of being used for preparing procaterol hydrochloride and preparation method thereof 四川美域高生物医药科技有限公司 2022-03-18 CN claimed
CN-114105872-A Intermediate for preparing procaterol hydrochloride and preparation method thereof 四川美域高生物医药科技有限公司 2022-03-01 CN claimed
CN-114094166-A Lithium ion battery non-aqueous electrolyte and lithium ion battery 北京胜能能源科技有限公司 2022-02-25 CN claimed
CN-110759946-A Functionalized reagent containing trimethyl piperidine group and triphenyl phosphorus group, and preparation method and application thereof 北京蛋白质组研究中心 2020-02-07 CN claimed
US-20040002613-A1 Synthesis of benzonitriles from substituted benzoic acid GENZYME CORPORATION 2004-01-01 US claimed
WO-2004000830-A1 NOVEL COMPOUNDS, THEIR USE AND PREPARATION BIOVITRUM AB (SE) 2003-12-31 WO claimed
US-6667415-B1 Dissolution inhibitors; sensitivity, resolution, process-ability; preservation stability SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-12-23 US claimed
WO-2003097582-A2 SYNTHESIS OF BENZONITRILES AND BENZIMIDATES GENZYME CORPORATION (US) 2003-11-27 WO claimed
US-20030073027-A1 Chemical amplification resist compositions and process for the formation of resist patterns FUJITSU LIMITED (JP) 2003-04-17 US claimed
WO-2003020793-A2 PROCESS FOR PREPARING POLYCARBONATE GENERAL ELECTRIC COMPANY (US) 2003-03-13 WO claimed
US-6504000-B1 Process for preparing polycarbonate GENERAL ELECTRIC COMPANY 2003-01-07 US claimed
US-20020042002-A1 Solid polymer electrolytes using polyether poly (N-substituted urethane) J.CHEM INCORPORATION (KR) 2002-04-11 US claimed
US-6200724-B1 CHEMICAL AMPLIFICATION RESIST COMPRISES AN ALKALI-SOLUBLE BASE RESIN, A PHOTOACID GENERATOR AND A DISSOLUTION INHIBITOR, IN WHICH A CYCLIC STRUCTURE FORMS A MATRIX PORTION CONTAINS ONE LONE PAIR CONTAINING PORTION FUJITSU LIMITED (JP) 2001-03-13 US claimed
EP-0308341-B1 PROCESS FOR THE INDUSTRIAL SYNTHESIS OF PERINDOPRIL AND FOR ITS PRINCIPAL SYNTHESIS INTERMEDIATES ADIR ET COMPAGNIE (FR) 1990-12-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002613-A1 Synthesis of benzonitriles from substituted benzoic acid FTH1, FGB, TXN2 CA9 4143/4885CA1 2547/4885CA2 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.